Although studies have shown that the complement-activation fragments in maternal plasma such as Bb, C3a, C5a are a significant risk factor for preeclampsia (14, 16), only few studies focused on the upstream complement protein such as adipsin. The gene discussed is C5; the disease is preeclampsia.